CNBC TV 18 Electronic, National September 19, 2013
|
|
- Samuel Collins
- 6 years ago
- Views:
Transcription
1 CNBC TV 18 Electronic, National September 19, tv18 comments/jj toresume ops at mulund plant after hc reprieve _ html
2 PTI Online September 19, 2013 HC relief for J&J, can restart Mulund factory Mumbai, Sep 19 (PTI) In a relief for the baby products maker Johnson and Johnson (J&J), the Bombay High Court today allowed the company to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. FDA had ordered shut down of the plant for not treating a batch of talcum powder for ethylene oxide residue in Outlook Online September 19, 2013 HC Relief for J&J, Can Restart Production at Mulund Unit In a relief for the baby products maker Johnson and Johnson (J&J), the Bombay High Court today allowed the company to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. FDA had ordered shut down of the plant for not treating a batch of talcum powder for ethylene oxide residue in The division bench of Justices S J Vazifdar and K R Shriram was hearing a petition filed by Johnson and Johnson challenging the June 24 order of FDA appellate authority. While allowing resumption of production, court today referred the matter back to the appellate authority for a reconsideration, saying that "the proportionality (of the punishment vis a vis the offence) issue needs to be seen". In March, FDA cancelled the licence of the Mulund factory after it found that 15 batches of baby talcum powder manufactured there in 2007 were sterilised using ethylene oxide, a chemical that is widely believed to be carcinogenic. FDA alleged that the company did not register the process with it, and failed to conduct tests for traces of ethylene oxide in the powder. The company challenged the order, but in June the cancellation of license was upheld by the FDA's appellate authority. Senior counsel Rafiq Dada, appearing for the company, said the company was not using ethylene oxide treatment process anymore. FDA counsel Ashutosh Kumbhakoni had, however, opposed the petition and said the company had not expressed any remorse even after the issue came to light.
3 Economic Times Online September 19, 2013 High Court relief for J&J, can restart production at Mulund factory PTI Sep 19, 2013, 09.35PM IST MUMBAI: In a relief for the baby products maker Johnson and Johnson (J&J), the Bombay High Court today allowed the company to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order ofmaharashtra Food and Drug Administration. FDA had ordered shut down of the plant for not treating a batch of talcum powder for ethylene oxide residue in The division bench of Justices S J Vazifdar and K R Shriram was hearing a petition filed by Johnson and Johnson challenging the June 24 order of FDA appellate authority. While allowing resumption of production, court today referred the matter back to the appellate authority for a reconsideration, saying that "the proportionality (of the punishment vis a vis the offence) issue needs to be seen". In March, FDA cancelled the licence of the Mulund factory after it found that 15 batches of baby talcum powder manufactured there in 2007 were sterilised using ethylene oxide, a chemical that is widely believed to be carcinogenic. FDA alleged that the company did not register the process with it, and failed to conduct tests for traces of ethylene oxide in the powder. The company challenged the order, but in June the cancellation of license was upheld by the FDA's appellate authority. Senior counsel Rafiq Dada, appearing for the company, said the company was not using ethylene oxide treatment process anymore. FDA counsel Ashutosh Kumbhakoni had, however, opposed the petition and said the company had not expressed any remorse even after the issue came to light.
4 Indian Express Mumbai September 20, 2013 Times of India Mumbai September 20, 2013
5 Mumbai Mirror Mumbai September 20, 2013
6 Maharashtra Times Mumbai, Nagpur September 20, 2013
7 Translation: Headline: The ban on Johnson has been lifted Mumbai: J&J used a sterilization process to reduce the chances of contracting cancer which could arise from strains of bacteria present in baby powder. But the ethylene oxide used for sterilization was above the permissible limits, which led to the FDA cancelling their Mulund Factory License. As per the High Court s decision, they have given J&J the green signal to resume manufacturing operations. The High Court on Thursday, advised the FDA to again appear for the hearing. In the year 2007, J&J manufactured 1,60,000 batches of talcum powder using cancerous substance ethylene oxide without the prior permissions to sterilize the powder. In return, the FDA had taken strict action against Johnson & Johnson and cancelled their manufacturing license for all products and took strict action against them. Post FDA s decision, J&J had filed an appeal in the High Court against cancellation of their license. The hearing was done in front of Judges SJ Vazifdar and MS Sonak. Post the decision, the judges has asked to complete the case with the appellate authority. Senior Advocate Ashutosh Kumbhakoni appeared for FDA in this case. Post receiving the directives from the High Court, J&J spokesperson informed, we will soon start the production of all their products at their Mulund Plant. Nothing is more important to us than the health of our consumers and we shall strive to win their confidence again, this is a very important decision for us.
8 Hindu Business Line Delhi, Mumbai, Chennai, Kochi, Hyderabad, Bangalore, Kolkata, Ahmedabad September 25, 2013
9 Hindu Business Line Online September 25, 2013 Bombay HC permits Johnson & Johnson to restart Mulund unit operations OUR BUREAU MUMBAI, SEP 24: The Bombay High Court has allowed Johnson & Johnson to resume its manufacturing activities at the Mulund plant in Mumbai. Johnson & Johnson (J&J) had lost its license to manufacture cosmetics at the plant, with the Maharashtra Food and Drug Administration finding the company guilty of using ethylene oxide in a limited number of batches of baby powder in Ethylene oxide is known to be a chemical that causes cancer. On the basis of a complaint, the Maharashtra Food and Drug Administration (FDA) had cancelled the company's Mulund plant licence. In 2007, 15 finished batches of Johnson baby powder were found to have higher ph levels than the prescribed limits. These batches were reprocessed for ph correction, to meet the quality specification. However, due to the excessive manual handling of these 15 batches during reprocessing, the batches at the finished goods stage were treated with ethylene oxide to reduce the anticipated increase in bio-burden. The product had an expiry date of However, on April 10, 2013, J&J received an order from the Maharashtra FDA cancelling its Cosmetic Manufacturing license at the Mulund plant, with effect from June 24. The company said the FDA did not issue a show cause notice to J&J before cancellation of the license. An appeal against the order was filed with the Ministry of FDA in Maharashtra, requesting for an immediate stay, but was rejected by the FDA Minister of Maharashtra. The company subsequently filed a writ petition on July 12, 2013 in the Bombay High Court challenging the FDA order. With the Bombay High Court setting aside the Maharashtra FDA order, the company has said it would resume cosmetic manufacturing at its Mulund plant in Mumbai in due course. ``We will continue to work closely with Maharashtra FDA, and provide safe, high quality products,'' said a J&J India spokesperson. The FDA action was specific to the cosmetics production at the Mulund plant in India and did not impact global manufacturing or any other plants in India, the company said.
10 ET Speed Online September 27, 2013 Sukumar CR Sukumar Johnson & Johnson To Resume Manufacture of Cosmetics At The Mulund Plant:The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration.
11 Indlawnews.com Online September 24, 2013 Bombay HC allows production in J&J Mulund unit, company welcomes (UNI) The Bombay High Court has quashed the Food and Drug Administration's (FDA) order which had cancelled the manufacturing licence of the Johnson & Johnson (J&J)'s unit situated in eastern suburb of Mulund. The decision of the court now allows the company's baby powder facility, which was shut since June 24, to resume production. The division bench of Justices S J Vazifdar and M S Sonak, while quashing the FDA's order yesterday, took into account 'compensation and closure' expense for the company, and observed that the matter was serious and must be looked into and reconsidered by the FDA minister, who is the appellate authority. The FDA had alleged that the company sterilized 15 batches of baby powder boxes in 2007 with 'carcinogenic' ethylene oxide and did not check for its residue. J&J, on their part, said that as part of an audit conducted in 2009, they had checked samples of three batches and found no residue. Reiterating their stand, they said, 'We will continue to work closely with Maharashtra FDA, and to provide India with safe, high quality products that help people care for themselves and their families.' J&J told the High Court that the 15 batches were brought back to its facility and tested according to a validated process before release into the market. Reacting to the High Court decision yesterday, J&J, in a statement released today, said, 'We are very pleased to inform you that the Bombay High Court has set aside the Maharashtra FDA order and we will be resuming cosmetic manufacturing at our Mulund plant in Mumbai in due course.' 'Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence,' it added. UNI
12 Bloomberg.com Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant PR Newswire MUMBAI, September 24, 2013 The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson. For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority.
13 Moneylife.in Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant PR Newswire MUMBAI, September 24, 2013 MUMBAI, September 24, 2013 /PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson. For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority. Pressclubmumbai.com Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant MUMBAI, September 24, 2013 /PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson.
14 For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority. Newstkr.com Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant MUMBAI, September 24, 2013 /PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson. For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority. Keralabiznews.com Online September 24, EURO_ND enin _indiapublic&dir=25
15 Indiatoday.intoday.in Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant MUMBAI,September 24, 2013/PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provideindiawith safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson,Indiaspokesperson. For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority. Headlinesindia.mapsofindia.com Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant MUMBAI, September 24, 2013 /PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, Indiaspokesperson. For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority.
16 Equityupdates.com Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant MUMBAI, September 24, 2013 /PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, Indiaspokesperson. For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority.
17 Blive.in September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant MUMBAI, September 24, 2013 /PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide Indiawith safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson. For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority.
18 Zeenewsindia.com Online September 24, 2013 Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant MUMBAI, September 24, 2013 /PRNewswire/ -- The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder. "Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson.
19 Dinakaran Chennai September 25, 2013 Translation: Headline: High Court has given permission to reopen the Johnson and Johnson mill at Mumbai Mumbai, September 25. The Mumbai High Court has given permission to reopen the Johnson and Johnson Muland mill at Mumbai yesterday. In 2007, there was an allegation raised against this company that high level of chemical substance which is injurious to the health of babies, was used for making the baby talc powder. Followed by this, Maharashtra Food and Drugs Administration had taken action against it. It cancelled the license for the production of cosmetic products of Johnson and Johnson industry. The company appealed against the cancellation of license to the Maharashtra Food and Drugs Administration. But, it rejected to cancel the order. After that, on 12 th July 2013 a case was filed in the Mumbai High Court on behalf of the company. After reviewed the case the court dismissed the order through its judgment. Followed by this, the spokesman of Johnson and Johnson Company said, we will give full cooperation to Maharashtra Food and Drugs Administration and we ll pay more attention to the welfare of the babies and we ll produce baby products in high standard. And, the Muland will be opened shortly.
20 Divya Gujarat Ahmedabad September 25, 2013 Johnson & Johnson to Resume Manufacture Of Cosmetics At The Mulund Plant The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honorable High Court passed this judgment after due consideration of all facts related to the case. The Court also found the company s offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder.
21 Ekmat Aurangabad September 25, 2013 Headline: Production of beauty products starts again Aurangabad: Bombay High Court has lifted the ban on production of baby products manufactured by Johnson & Johnson at their Mulund plant. The manufacturing of these products were stopped as per the directives of the FDA.
22 Sindhudurg Samachar Kolhapur September 26, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
23 Kesari Kolhapur September 26, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
24 Pudhari Kolhapur September 26, 2013 Translation: Headline: Bombay HC decision gives Johnson and Johnson respite They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
25 Vishwamitra Aurangabad September 26, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
26 Mahasagar Nagpur September 26, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
27 Jai Hind Ahmedabad September 26, 2013 Johnson & Johnson To Resume Manufacture Of Cosmetics At The Mulund Plant The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honourable High Court passed this judgment after due consideration of all facts related to the case. The Court also found the company s offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder.
28 Malenadu Mitra Shimoga September 27, 2013 Translation Headline: Bombay High Court permits Johnson & Johnson to manufacture Baby Powder Bangalore: The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund plant, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Court passed this judgment after due consideration of all facts related to the case. The Court also found the company s offer to test the batches of baby powder in question, reasonable. Further, the court also observed that there was no scientific basis that there were any carcinogens present in that batch of baby powder.
29 Vijay Karnataka Bijapur September 27, 2013
30 New Age Kerala September 27, 2013 Translation: Headline: Johnson & Johnson plant started manufacturing Cochin: Baby product manufacturers Johnson & Johnson restarted the manufacturing of baby powder at its Mulund unit. Its manufacture had been stopped upon the order of Maharashtra Food and Drug Administration. The permission to restart baby powder manufacture was given by Bombay High court. The High court passed the judgment after due consideration of all facts related to the case. The court found the company s offer to test the batches of baby powder in question reasonable. There is no scientific foundation that there were any carcinogens present in the batch of baby powder in question. The company sources said that for the past 100 years, Johnson & Johnson has earned trust of over one billion families and health care professionals. He said that our commitment to safety, health and wellness of our consumers will always be our top priority.
31 Veekshanam Kerala September 27, 2013 Translation: Headline: Johnson & Johnson plant started manufacturing Cochin: Baby product manufacturers Johnson & Johnson restarted the manufacturing of baby powder at its Mulund unit. Its manufacture had been stopped upon the order of Maharashtra Food and Drug Administration. The permission to restart baby powder manufacture was given by Bombay High court. The High court passed the judgment after due consideration of all facts related to the case. The court found the company s offer to test the batches of baby powder in question reasonable. There is no scientific foundation that there were any carcinogens present in the batch of baby powder in question. The company sources said that for the past 100 years, Johnson & Johnson has earned trust of over one billion families and health care professional s.he said that our commitment to safety, health and wellness of our consumers will always be our top priority.
32 Chandrika Kochi September 27, 2013 Translation: Headline: Johnson & Johnson plant started manufacturing Cochin: Baby product manufacturers Johnson & Johnson restarted the manufacturing of baby powder at its Mulund unit. Its manufacture had been stopped upon the order of Maharashtra Food and Drug Administration. The permission to restart baby powder manufacture was given by Bombay High court. Desabhimani Kerala September 27, 2013 Translation: Headline: Johnson & Johnson plant restarted manufacturing Cochin: Baby product manufacturers Johnson & Johnson restarted the manufacturing of baby powder at its Mulund unit. Its manufacture had been stopped upon the order of Maharashtra Food and Drug Administration. The permission to restart baby powder manufacture was given by Bombay High court.
33 Siraj Kochi September 27, 2013 Translation: Headline: Johnson & Johnson plant started manufacturing Cochin: Baby product manufacturers Johnson & Johnson restarted the manufacturing of baby powder at its Mulund unit. Its manufacture had been stopped upon the order of Maharashtra Food and Drug Administration. The permission to restart baby powder manufacture was given by Bombay High court. The High court passed the judgment after due consideration of all facts related to the case. The court found the company s offer to test the batches of baby powder in question reasonable.the company sources said that there is no scientific foundation that there were any carcinogens present in the batch of baby powder in question.
34 Janmabhumi Kerala September 27, 2013 Translation: Headline: Johnson & Johnson plant started manufacturing Cochin: Baby product manufacturers Johnson & Johnson restarted the manufacturing of baby powder at its Mulund unit. Its manufacture had been stopped upon the order of Maharashtra Food and Drug Administration. The permission to restart baby powder manufacture was given by Bombay High court. The High court passed the judgment after due consideration of all facts related to the case.
35 Tamil Suder Chennai September 27, 2013 Translation: Headline: Johnson and Johnson Mulund plant started production again Chennai, September 27. Mumbai High Court has given permission Johnson and Johnson, the producer of baby products, to restart the baby talc powder production at Mulund unit which was stopped by an order issued by the Maharashtra Food and Drugs Administration. After reviewing all the facts deeply, the respectful High court gave this judgment. By its reasonable questions the court also considered the company s testing scope by groups. Furthermore, the court gave the permission by saying that there is no concrete scientific evidence for the growth of inducement of cancer in the groups of baby talc powder.
36 Sanjevani Bangalore September 27, 2013 Translation: Headline: Johnson & Johnson to resume manufacture of cosmetics at the Mulund Plant The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Honorable High Court passed this judgment after due consideration of all facts related to the case. The Court also found the company s offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in the batch of baby powder under consideration.
37 Gujarat Niti Ahmedabad September 28, 2013 Standard Herald Ahmedabad September 28, 2013
38 Dina Vanigam Chennai September 28, 2013
39 Dina Bhoomi Chennai September 28, 2013 Vartha Hyderabad September 28, 2013
40 Andhra Prabha Hyderabad September 28, 2013 Lokmat Samachar Kolhapur September 30, 2013 Translation: Headline: High Court gives relief Kolhapur: Bombay High Court has given the permission to Johnson and Johnson to resume manufacturing of their baby powder in their Mulund factory. FD had ordered to stop the production. HC has passed the order after considering and looking deeply into all the facts and evidences. The testing of Baby powder was also a feasible step. The is no scientific base to the fact that there were presence of carcinogenic substances in the baby powder.
41 Janpatra Aurangabad September 30, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
42 Shivnateer Aurangabad September 30, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
43 Tarun Bharat Aurangabad September 30, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
44 Mahavidarbha Nagpur September 30, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant They have started their production starting from today. The same had been stopped by the FDA, Maharashtra. Honorable High Court has studied the entire case and given this decision. Company s proposal of testing the baby powder was found to be feasible by the HC. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
45 Yugdharma Nagpur September 30, 2013 Translation: Headline: Johnson & Johnson will start manufacturing of cosmetic goods at their Mulund plant Bombay HC has rejected the pleas of the FDA and given permission to Johnson and Johnson to resume manufacturing of cosmetic goods at their Mulund plant.. Nothing is more important to us than the well being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families, said a Johnson & Johnson, India spokesperson.
46 Ee Sanje Mangalore September 30, 2013 Translation: Headline: Bombay High Court permits Johnson & Johnson to manufacture Baby Powder Bangalore: The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund plant, which had been stopped upon the order of Maharashtra Food and Drug Administration. The Court passed this judgment after due consideration of all facts related to the case. The Court also found the company s offer to test the batches of baby powder in question, reasonable. Further, the court also observed that there was no scientific basis that there were any carcinogens present in that batch of baby powder.
47 Vartha Bharathi Tumkur September 30, 2013 Metro Vartha Kerala September 30, 2013
48 Murasu Chennai September 30, 2013
49 Divya Bhaskar Ahmedabad September 30, 2013 Swarganga Aurangabad October 1, 2013
50 Sahyadri Times Aurangabad October 1, 2013 Dainik Bhaskar Nagpur October 2, 2013
51 Samaj Kolhapur October 3, 2013
52 Now Indiar Times Chennai October 4, 2013 Kathir Mathu Chennai October 4, 2013
53 Madurai Mani Chennai October 4, 2013 Namathu Murasu Chennai October 4, 2013
54 Punya Nagri Nagpur, Aurangabad October 4, 2013 Nav Sandesh Kolhapur October 4, 2013
55 Krantisinha Kolhapur October 4, 2013 Rashtratej Pune October 5, 2013
56 Lokshahi Varta Nagpur October 7, 2013 Saanjwarta Pune October 8, 2013
57 Saanj Samachar Pune October 8, 2013
What if someone complains about me? A guide to the complaint process
What if someone complains about me? A guide to the complaint process Introduction The purpose of the licensed building practitioner scheme is to set performance standards for building practitioners and
More informationNOTIFICATION NO Different cooling off periods applicable for re-admission to Bureau membership - Publisher Members
Audit Bureau Of Circulations Founder Member : International Federation Audit Bureaux Circulations Wakefield House, Sprott Road, Ballard Estate, Mumbai 400 001 Tel: 2261 18 12 / 2261 90 72. Fax: 2261 88
More informationRegulatory Reforms-Future of Plasma Protein Therapy in India
Regulatory Reforms-Future of Plasma Protein Therapy in India Ranjeet S. Ajmani PlasmaGen BioSciences Pvt. Ltd. Bangalore, India PPB-2013 Price Tag of Contrast q Uniqueness q Co-existence : Rich & Poor
More information* THE HIGH COURT OF DELHI AT NEW DELHI. versus J U D G E M E N T
* THE HIGH COURT OF DELHI AT NEW DELHI + W.P.(C) 6913/2015 JACOB PULIYEL Through: Pronounced on: October 14, 2015... Petitioner Mr.Prashant Bhushan with Ms.Nidhi Rathi, Mr.Sudhakar T., Advs. versus UNION
More informationCOVERAGE REPORT Launch of India s largest breast cancer screening drive by Tata Trusts, Prashanti Cancer Care and Swasth India
COVERAGE REPORT Launch of India s largest breast cancer screening drive by Tata Trusts, Prashanti Cancer Care and Swasth India Page 1 of 55 Article Date Headline / Summary Publication Edition Page No.
More informationThe Boston Globe. March 8, 2010 Monday
The Boston Globe March 8, 2010 Monday FDA lax on conflicts of interest SECTION: EDITORIAL OPINION; Opinion; Pg. 10 LENGTH: 339 words THE FOOD and Drug Administration has done far too little to avoid conflicts
More informationCMA Response: Health Canada s Medical Marihuana Regulatory Proposal. Submitted to the Office of Controlled Substances Health Canada.
CMA Response: Health Canada s Medical Marihuana Regulatory Proposal Submitted to the Office of Controlled Substances Health Canada February 28, 2013 A healthy population and a vibrant medical profession
More informationDr. Jacob Roy Kuriakose, Chairman, Alzheimer s Disease International
Dr. Jacob Roy Kuriakose, Chairman, Alzheimer s Disease International Agenda Dementia A Significant Challenge in India Importance of Advocacy in Dealing with Dementia Dementia India Report Recommendations
More informationEvery Life is Precious!
Every Life is Precious! Scenario Analysis Healthcare has seldom been considered a priority in India. Amid a growing and changing demography, large gaps still remain in the ability of the country s government
More informationBERMUDA DENTAL HYGIENISTS REGULATIONS 1950 SR&O 37 / 1950
QUO FA T A F U E R N T BERMUDA DENTAL HYGIENISTS REGULATIONS 1950 SR&O 37 / 1950 [made under section 28 of the Dental Practitioners Act 1950 and brought into operation on 11 December 1950] TABLE OF CONTENTS
More informationIN THE SUPREME COURT OF INDIA CIVIL APPELLATE JURSIDCITON CIVIL APPEAL NOS OF 2015
1 IN THE SUPREME COURT OF INDIA CIVIL APPELLATE JURSIDCITON REPORTABLE CIVIL APPEAL NOS. 4822-4825 OF 2015 COMMISSIONER OF CENTRAL EXCISE & SERVICE TAX, BANGALORE APPELLANT VERSUS M/S KARNATAKA SOAPS &
More informationHEARING DOJ DOJ DOJ DOJ Modified Parity case. Appeal allowed. DOJ DOJ
Ite m STATUS OF THE CASES OF PRE 2006 PENSIONERSS IN VARIOUS COURTS : AS ON 01.09.2012 COMPILED BY M. L. KANAUJIA, IRSSE / Chief Communication Engineer, N.E. Railway, (Rtd.) NEXT HEARD BY DATE PETITION
More informationIllinois Supreme Court. Language Access Policy
Illinois Supreme Court Language Access Policy Effective October 1, 2014 ILLINOIS SUPREME COURT LANGUAGE ACCESS POLICY I. PREAMBLE The Illinois Supreme Court recognizes that equal access to the courts is
More informationMedical marijuana or employment - a tough decision for some
Medical marijuana or employment - a tough decision for some Published: Thursday, October 06, 2011 By SEAN DEALTON For The Oakland Press Of the more than 100,000 registered medical marijuana-using patients
More informationENGLESKI JEZIK. 02. Every time Jim came to see Jill, her some flowers. a) he d bring b) he d brought c) he ll bring
12.00 h I GRUPA ENGLESKI JEZIK 01. I ll inform you as soon as we the results. a) will be hearing b) shall hear c) have heard 02. Every time Jim came to see Jill, her some flowers. a) he d bring b) he d
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
More informationNew Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs
Central Drugs Standard Control Organization Directorate General of Health Services Ministry of Health and Family Welfare Government of India New Drugs Division Frequently Asked Questions (FAQs) on Approval
More informationKING COUNTY SUPERIOR COURT, WASHINGTON STATE CAUSE NO SEA
KING COUNTY SUPERIOR COURT, WASHINGTON STATE CAUSE NO. 11-2-34187-9 SEA ATTENTION: CURRENT AND PRIOR REGENCE BLUESHIELD INSUREDS WHO CURRENTLY REQUIRE, OR HAVE REQUIRED IN THE PAST, SPEECH, OCCUPATIONAL
More informationIN THE HIGH COURT OF DELHI AT NEW DELHI (CIVIL ORIGINAL JURISDICTION)
IN THE HIGH COURT OF DELHI AT NEW DELHI (CIVIL ORIGINAL JURISDICTION) C.M. No. OF 2013 IN WRIT PETITION (CIVIL) No. 13698 OF 2009 PUBLIC INTEREST LITIGATION IN THE MATTER OF: DR. K. B. SAXENA & ORS. PETITIONERS
More informationFamily & Individual Support Program - Handbook
Family & Individual Support Program - Handbook Welcome and Introduction to the Simon Fraser Society for Community Living Welcome to the Simon Fraser Society for Community Living (SFSCL). We have been serving
More informationPublic Health Foundation of India CCEBDM & CCGDM Convocation Thane (Maharashtra)
Public Health Foundation of India CCEBDM & CCGDM Convocation Thane (Maharashtra) Welcome Address delivered by Dr. Benny Negalur. Dignitaries on dais from L to R (Dr. Sandeep Bhalla, Dr. Ajay Thakkar, Dr.
More informationPublic Minutes of the Investigation Committee
Public Minutes of the Investigation Committee Date of hearing: Name of Doctor Dr Mavji Manji Doctor s UID 3255274 Committee Members Mr John Anderson (Chair) Mr David Hull (Lay) Dr Zahir Mohammed (Medical)
More informationHow Ofsted regulate childcare
Information for parents about Ofsted s role in regulating childcare This section provides information about how Ofsted regulates childcare providers. It sets out how you might like to use the information
More informationCANNABIS IN YOUR COMMUNITY. A Presentation to CPAA Conference May 2017
CANNABIS IN YOUR COMMUNITY A Presentation to CPAA Conference May 2017 WE LL BE THERE FOR YOUR HIGHS AND LOWS! Presented by: MUNICIPAL Charlotte A. St. Dennis Senior Associate Edmonton Office cstdennis@brownleelaw.com
More informationCommonwealth of Kentucky Court of Appeals
RENDERED: JULY 9, 2010; 10:00 A.M. NOT TO BE PUBLISHED Commonwealth of Kentucky Court of Appeals NO. 2009-CA-002309-WC PALM BEACH COMPANY APPELLANT PETITION FOR REVIEW OF A DECISION v. OF THE WORKERS COMPENSATION
More informationMEDICAL AND GERIATRIC SUSPENSION OF SENTENCE
The District of Columbia provides compassionate release to prisoners who have serious medical conditions or are elderly through (1) Medical and Geriatric Suspension of Sentence 1 and (2) Medical and Geriatric
More informationExhibit 2 RFQ Engagement Letter
Exhibit 2 RFQ 17-25 Engagement Letter The attached includes the 6 page proposed engagement letter to be used by HCC. ENGAGEMENT LETTER Dear: [Lead Counsel/Partner] We are pleased to inform you that your
More informationBREAST CANCER. Globocan Report 2012
BREAST CANCER CANCER is the most deadly word a patient can hear from the doctor. It is the most dreaded disease and second cause of death after cardiovascular diseases. Among different types of cancer,
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
More informationSection 32: BIMM Institute Student Disciplinary Procedure
Section 32: BIMM Institute Student Disciplinary Procedure Introduction Academic Development & Quality Assurance Manual This Student Disciplinary Procedure provides a framework for the regulation of BIMM
More informationBEFORE: MR JUSTICE MOYLAN BETWEEN: AN NHS TRUST Applicant. - And. CHILD B AND MR & MRS B Respondents
The judgment is being distributed on the strict understanding that in any report no person other than the advocates or the solicitors instructing them may be identified by name or location. In particular
More informationMETROLINX ADMINISTRATIVE FEE DISPUTE RESOLUTION PROCESS RULES OF PRACTICE
METROLINX ADMINISTRATIVE FEE DISPUTE RESOLUTION PROCESS RULES OF PRACTICE Overview The Metrolinx Act, 2006, gives Metrolinx ( Metrolinx ) the authority to establish a system of administrative fees to ensure
More informationFROST & SULLIVAN. Publications Division - Terms and Conditions of Business
FROST & SULLIVAN Publications Division - Terms and Conditions of Business 1. Frost & Sullivan and FICCI takes no responsibility for any incorrect information supplied by manufacturers or users. Quantitative
More informationCHAPTER TWO: TRENDS IN FAMILY PLANNING USE AND PUBLIC SECTOR OUTLAY IN INDIA
CHAPTER TWO: TREDS I FAMILY PLAIG USE AD PUBLIC SECTOR OUTLAY I IDIA 2.1 Introduction: This chapter examines the trends in use of family planning methods, changes in use of family planning methods over
More informationChapter 14 Support for parents and caregivers
179 Chapter 14 Support for parents and caregivers All over the world, parents and other family members work very hard caring for their young children. And when a family has a child who cannot hear, there
More informationACLU of Pennsylvania ~ Clean Air Council Delaware Riverkeeper Network
For Immediate Release May 31, 2016 ACLU of Pennsylvania ~ Clean Air Council Delaware Riverkeeper Network Contacts: Sara Mullen, ACLU of Pennsylvania: 215 592 1513 x 122 Maya van Rossum, the Delaware Riverkeeper,
More informationBest Practices in Smokeless Tobacco Control
ICMR- NATIONAL INSTITUTE OF CANCER PREVENTION & RESEARCH Best Practices in Smokeless Tobacco Control Workshop on Priorities in Smokeless Tobacco Control Research and Training needs 27-28 November, 2017
More informationA SOCIAL JUSTICE CHALLENGE FOR 21 ST CENTURY SCOTLAND: MEETING THE HOUSING NEEDS OF PEOPLE IN AND LEAVING PRISON
A SOCIAL JUSTICE CHALLENGE FOR 21 ST CENTURY SCOTLAND: MEETING THE HOUSING NEEDS OF PEOPLE IN AND LEAVING PRISON HEALTH AND HOMELESSNESS CONFERENCE 29 MARCH 2018 LIZ COOPER, POLICY MANAGER (HOUSING AND
More informationWhat to expect in the hearing room
What to expect in the hearing room Page 1 of 6 1. Coat of Arms / Canadian flag Most hearing rooms have a Canadian flag next to the Board member's table and a Coat of Arms on the wall behind the Board member.
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,
More informationFACT SHEET PREPARED BY THE MINISTRY OF JUSTICE ON THE DANGEROUS DRUGS (AMENDMENT) ACT 2015 OVERVIEW 1. This Fact Sheet sets out the main changes that have been made to the Dangerous Drugs Act (the DDA
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
More informationPREVENTION AND EARLY DETECTION OF CANCER. Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:
GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE LOK SABHA UNSTARRED QUESTION NO. 2212 TO BE ANSWERED ON 28 TH JULY, 2017 PREVENTION AND EARLY DETECTION
More informationSUMMARY OF THE DIABETIC RETINOPATHY AND RETINOPATHY OF PREMATURITY INITIATIVES IN INDIA MID-TERM REVIEW
SUMMARY OF THE DIABETIC RETINOPATHY AND RETINOPATHY OF PREMATURITY INITIATIVES IN INDIA MID-TERM REVIEW Review conducted by Amaltas, India. Submitted January 2017 AN INDEPENDENT REVIEW OF THE TRUST S DIABETIC
More informationState Level Advocacy Meeting for Effective Implementation of Smoke Fee Laws
State Level Advocacy Meeting for Effective Implementation of Smoke Fee Laws Jaipur, Rajasthan, June 10, 2009 Introduction CUTS Centre for Consumer Action, Research & Training (CUTS CART) jointly with the
More informationBERMUDA DENTAL TECHNICIANS REGULATIONS 1962 BX 6 / 1962
QUO FA T A F U E R N T BERMUDA DENTAL TECHNICIANS REGULATIONS 1962 BX 6 / 1962 TABLE OF CONTENTS 1 2 3 4 5 6 7 8 9 10 11 12 15 Citation Interpretation Unqualified persons; offences Register of dental technicians
More informationMEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 1 ST APRIL, 2014 IN THE CHAMBER OF DGHS, NIRMAN BHAWAN, NEW DELHI
MINUTES OF THE 67 TH MEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 1 ST APRIL, 2014 IN THE CHAMBER OF DGHS, NIRMAN BHAWAN, NEW DELHI PRESENT 1. Dr. Jagdish Prasad, Chairman Director General of Health
More informationAccess to Healthcare for Women and Children. A Philips CSR Initiative. Sumathi/ Anoop 8/31/17 An overview
Access to Healthcare for Women and Children A Philips CSR Initiative Sumathi/ Anoop 8/31/17 An overview A BRIEF ABOUT THE COMPANY PHILIPS INDIA LTD About Philips Philips India Limited is a subsidiary of
More informationReturn Date: February 27, 2002
Return Date: February 27, 2002 Time: 9:30 a.m. COUCH WHITE, LLP 540 Broadway P.O. Box 22222 Albany, New York 12201-2222 (518) 426-4600 Harold N. Iselin, Esq. (H.I. 1428) James J. Barriere, Esq. (J.B. 3206)
More informationInitiative of Maharashtra State AIDS Control Society. Status of Targeted Intervention Project since 1999
Targetted Interventions Non Governmental Organisation Activities Priority Targeted Intervention for Groups at High Risk. The objective of Targeted Intervention Programme is to reduce the rate of transmission
More informationIN THE SUPREME COURT OF INDIA CIVIL ORIGINAL JURISDICTION I.A. No. OF 2013 IN WRIT PETITION (CIVIL) NO. 565 OF 2012 VERSUS
1 IN THE SUPREME COURT OF INDIA CIVIL ORIGINAL JURISDICTION I.A. No. OF 2013 IN WRIT PETITION (CIVIL) NO. 565 OF 2012 IN THE MATTER OF: NIPUN SAXENA AND ANR. Petitioners VERSUS UNION OF INDIA AND ORS Respondents
More informationNOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL
NOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL Appellant: [X] (Worker) Participant entitled to respond to the appeal: Workers Compensation Board of Nova Scotia (Board) S.251 REFERRAL TO HEARING OFFICER
More informationINDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2
G B Pant Hospital J L Nehru Marg, Delhi Cardiac Anaesthesia 1 Delhi-110002 Indraprastha s Delhi Cardiac Anaesthesia 1 Medanta- The Medicity Sector-38, Gurgaon, Haryana Cardiac Anaesthesia 5 Haryana-122001
More informationMEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA
MEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA Document No.: MCA/NSG/17/11/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017
More informationThe Clean Environment Commission. Public Participation in the Environmental Review Process
The Clean Environment Commission Public Participation in the Environmental Review Process Manitoba Clean Environment Commission Who are we? The Manitoba Clean Environment Commission is an arms-length agency
More informationHEALTHCARE OF ELDERLY PEOPLE. Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:
1871. SHRI R. PARTHIPAN: GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE LOK SABHA UNSTARRED QUESTION NO. 1871 TO BE ANSWERED ON 29 TH DECEMBER, 2017 HEALTHCARE
More informationIn re: ) ) NOTICE OF CHARGES John E. Marshall, M.D., ) AND ALLEGATIONS; ) NOTICE OF HEARING Respondent. )
BEFORE THE NORTH CAROLINA MEDICAL BOARD In re: ) ) NOTICE OF CHARGES John E. Marshall, M.D., ) AND ALLEGATIONS; ) NOTICE OF HEARING Respondent. ) The North Carolina Medical Board ( Board ) has preferred
More informationProduced by Unit for Science Dissemination, CSIR, Anusandhan Bhawan, 2 Rafi Marg, New Delhi
1 Over 13K patents bagged by CSIR in last 3 fin yrs: Minister CSIR 15 th December 2016 The Council for Scientific and Industrial Research (CSIR) bagged 13,365 patents in the last three financial years
More informationFamily & Individual Support Program - Handbook
Family & Individual Support Program - Handbook Welcome to the Simon Fraser Society for Community Living (SFSCL). The SFSCL is an accredited not-for-profit, charitable organization that has been serving
More informationFIXED DRUG COMBINATIONS MAINS MODULE 1
FIXED DRUG COMBINATIONS MAINS MODULE 1 Fixed drug Combinations are medicines that contains two or more active components in fixed proportions in a single dosage form or several medications in fixed combination
More information[Cite as Columbus Bar Assn. v. Hayes, 118 Ohio St.3d 336, 2008-Ohio-2466.]
[Cite as Columbus Bar Assn. v. Hayes, 118 Ohio St.3d 336, 2008-Ohio-2466.] COLUMBUS BAR ASSOCIATION v. HAYES. [Cite as Columbus Bar Assn. v. Hayes, 118 Ohio St.3d 336, 2008-Ohio-2466.] Attorneys at law
More informationReview of Global Medicine and Healthcare Research
Review of Global Medicine and Healthcare Research Volume 3 No. 2 (2012) Publisher: DRUNPP Managed by: IOMC Group A Study on Knowledge, Attitude and Practices of Truck drivers regarding HIV/AIDS Patil Sandip
More informationLurz, Sally v. International Paper Company
University of Tennessee, Knoxville Trace: Tennessee Research and Creative Exchange Tennessee Court of Workers' Compensation Claims and Workers' Compensation Appeals Board Law 9-20-2017 Lurz, Sally v. International
More informationThe Important Role of Advocacy. The Challenge of Governance
The Important Role of Advocacy The Challenge of Governance September 2005 The Important Role of Advocacy page 1 Healthcare Trustees of New York State (HTNYS) represents the governing board members of the
More informationCAMPAIGN BRIEF: WHY DO WE NEED ACTION ON DEMENTIA?
CAMPAIGN BRIEF: WHY DO WE NEED ACTION ON DEMENTIA? Changes in Government Policy The Government has terminated the Dementia Initiative and risks squandering 6 years of investment. The Dementia Initiative
More informationEarlier this year, I had the honour of visiting with the Hope Haven Society in Lac La Biche.
Check Against Delivery Alberta Council of Women's Shelters AGM Friday, June 22 Delta Edmonton Centre Suite Hotel Edmonton Hon Dave Hancock, Minister, Human Services Good evening everyone. On behalf of
More informationSUMMARY DECISION NO. 1018/97. Permanent impairment (degree of impairment) (hearing loss).
SUMMARY DECISION NO. 1018/97 Permanent impairment (degree of impairment) (hearing loss). The worker appealed a decision of the Senior NEL Adjudicator granting a 5% NEL award for hearing loss and a 2% award
More informationThe. What-if? Workbook. How to Make Decisions About Your Mental Health Treatment. Ahead of Time. w i t h a d va n c e d i r e c t i v e s
The What-if? Workbook How to Make Decisions About Your Mental Health Treatment Ahead of Time w i t h a d va n c e d i r e c t i v e s The What-If? Workbook How to Make Decisions About Your Mental Health
More informationMental Health Bill 2011: Exposure Draft
Submission Mental Health Bill 2011: Exposure Draft September 2011 beyondblue PO Box 6100 HAWTHORN WEST VIC 3122 Tel: (03) 9810 6100 Fax: (03) 9810 6111 www.beyondblue.org.au beyondblue Mental Health Bill
More information- Notification to specify uniform limit (Ministry of Health, Labour and Welfare Notification No. 497, 2005)
Syoku-An No.1129001 November 29, 2005 *1 Director Notice *2 Department of Food Safety Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare Establishment of Applicable Laws and Ordinances
More informationVision/Lifestyle Questionnaire
Roger J. Meyer, M.D. Retina Fellowship Trained Macular Degeneration Diabetic Eye Care Glaucoma Robert M. Reinauer, M.D. Retina Fellowship Trained Surgical/Medical Treatment of the Retina & Vitreous Macular
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SINGLE TECHNOLOGY APPRAISAL APPEAL HEARING
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SINGLE TECHNOLOGY APPRAISAL APPEAL HEARING Advice on pirfenidone for treating idiopathic pulmonary fibrosis (review of TA282) [ID837] Decision of the panel
More informationGuidance for Witnesses
Guidance for Witnesses Introduction Giving evidence before the Fitness to Practise Committee of the General Pharmaceutical Council is likely to be unfamiliar to you and can seem to be a daunting process.
More informationFAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009
FAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009 Introduction The NATA considers the Joint Statement on Cooperation a very positive resolution
More informationReport on Industrial Visit to Yakult Danone India (P) Ltd, HSIIDC Industrial Area, Rai, Sonepat, Haryana. Organized for. BBA-IV Sem-II Shift,
Report on Industrial Visit to Yakult Danone India (P) Ltd, HSIIDC Industrial Area, Rai, Sonepat, Haryana Organized for BBA-IV Sem-II Shift, Tecnia Institute Of Advanced Studies, Madhuban Chowk, Rohini,
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
More informationTAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT
TAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT 1 Fighting breast cancer is a very emotional battle for women. Doctors are trying to save the lives of women by trying new and innovative methods and drugs. One
More informationA REPORT ON INDUSTRIAL VISIT AT AMUL
A REPORT ON INDUSTRIAL VISIT AT AMUL Photo 1: Main Gate Entry, Amul, Anand Address: Amul Dairy Road, Anand- 388 001, Gujarat, Date of Visit : 7th April, 2016 Time : 2:00 pm to 4:30 pm No. of Students :
More informationFollow this and additional works at:
2007 Decisions Opinions of the United States Court of Appeals for the Third Circuit 7-16-2007 USA v. Eggleston Precedential or Non-Precedential: Non-Precedential Docket No. 06-1416 Follow this and additional
More informationCURRICULUM VITAE. : Flat no.6, Mallika, Makarand Society, Savarkar Marg, Mahim, Mumbai , India
CURRICULUM VITAE Name : Dr. Arun Bhikedeo Bal Date of Birth : 1 st April 1951 Permanent Address Clinic Address : Flat no.6, Mallika, Makarand Society, Savarkar Marg, Mahim, Mumbai 400016, India : Talwalkar
More informationParticipants City of Pittsburgh Zone 4 police (5 participants), service providers (6 participants), persons in recovery (four participants)
Allegheny County Coalition for Recovery Committee for Recovery Dialogues (CRD) Trialogue March 8, 2018 Jewish Community Center of Greater Pittsburgh, Squirrel Hill Participants City of Pittsburgh Zone
More informationPROTECTING THE SPORT: GUIDE TO FEDERATION RULE ENFORCEMENT AND HEARING PROCESS
PROTECTING THE SPORT: GUIDE TO FEDERATION RULE ENFORCEMENT AND HEARING PROCESS COVER PHOTO:SHAWN MCMILLEN INTRODUCTION This pamphlet has been drafted to provide general information and to help you understand
More informationLisa Mirabile v. Comm Social Security
2009 Decisions Opinions of the United States Court of Appeals for the Third Circuit 12-7-2009 Lisa Mirabile v. Comm Social Security Precedential or Non-Precedential: Non-Precedential Docket No. 09-1446
More informationCHAPTER 2. Denturists Act
1st SESSION, 62nd GENERAL ASSEMBLY Province of Prince Edward Island 52 ELIZABETH II, 2003 CHAPTER 2 (Bill No. 20) Denturists Act Honourable J. Chester Gillan Minister of Health and Social Services GOVERNMENT
More informationAll member States were represented, except Bulgaria and Czech Republic
SANCO D1(2007)D/412302 SUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 5 OCTOBER 2007 SECTION TOXICOLOGICAL SAFETY OF THE FOOD CHAIN President : Mrs Patricia
More informationii. To support India s trade-related training institutions in strengthening their capacities.
EU-India Capacity Building Initiative for Trade Development in India - CITD INSTITUTIONAL SUPPORT AND TRAINING REGARDING THE EU DIRECTIVE 2004/24/EC ON HERBAL MEDICINES 0. INTRODUCTION The Project (EU-India
More informationIN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA LISA SYKES and SETH SYKES, : CIVIL ACTION Individually and as Parents and Natural : Guardians of WESLEY ALEXANDER : NO. SYKES,
More informationBoehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence
Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence Producing Value Boehringer Ingelheim
More informationDate: November 28, 2010 Edition: Bangalore. The Times of India
Date: November 28, 2010 Edition: Bangalore The Times of India Date: November 28, 2010 Edition: Bangalore The New Indian Express Date: November 28, 2010 Edition: Bangalore DNA Date: November 29, 2010 Edition:
More informationMs channel weight chart
Ms channel weight chart SS303, SS304, 304L, 308, 309, 309L, 310, 316, 316L, 321. MAHAVIR STEEL INDUSTRIES developes specific sections. Specific sizes in any section can be developed for economical and
More informationNAT (National AIDS Trust) Corporate Support
NAT (National AIDS Trust) Corporate Support ABOUT NAT (National AIDS Trust) NAT is the HIV charity dedicated to transforming the UK s response to HIV. Founded in 1987, we champion the rights of people
More informationRepresenting the FASD Affected Client Patricia Yuzwenko Youth Criminal Defence Office
1 Representing the FASD Affected Client Patricia Yuzwenko Youth Criminal Defence Office All lawyers should read the excellent article by David Boulding on this topic. I do not wish to repeat what he has
More informationWEST COAST DISTRICT MUNICIPALITY SUBSTANCE ABUSE POLICY
WEST COAST DISTRICT MUNICIPALITY SUBSTANCE ABUSE POLICY POLICY CONTROL SHEET POLICY TITLE : Substance Abuse Policy POLICY CUSTODIAN : West Coast District Municipality POLICY AUTHOR : H Brand LLF CONSULTATION
More informationProposed Revisions to the Procedure for Adjusting Grievances
Proposed Revisions to the Procedure for Adjusting Grievances 8 VAC 20-90-10 et seq. Presented to the Board of Education February 27, TABLE OF CONTENTS Part I Definitions 3 Part II Grievance Procedure Purpose
More informationBasic guidelines for promotion of control measures for hepatitis
Basic guidelines for promotion of control measures for hepatitis May 16, 2011 Table of Contents Chapter 1 Basic approach for preventing hepatitis and promoting medical care of hepatitis - 2 - Chapter 2
More information### About Bharat Biotech
Press Release Bharat Biotech Bharat Biotech Launches Typbar-TCV, world s first clinically proven typhoid conjugate vaccine for infants 6 months & older and Adults The new vaccine brings hope to millions
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2902/16
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2902/16 BEFORE: V. Marafioti : Vice-Chair S.T. Sahay : Member Representative of Employers A. Grande : Member Representative of Workers HEARING:
More informationInfluenza A(H1N1) aka Swine Flu. IAP ACVIP statement on ongoing outbreak of H1N1 in India. Situational analysis: Historical perspectives
Influenza A(H1N1) aka Swine Flu IAP ACVIP statement on ongoing outbreak of H1N1 in India Situational analysis: Historical perspectives H1N1 pandemic in 2009-10: The pandemic of A (H1N1) was first reported
More informationINDIAN COUNCIL OF MEDICAL RESEARCH DIVISION OF EPIDEMIOLOGY & COMMUNICABLE DISEASES
INDIAN COUNCIL OF MEDICAL RESEARCH DIVISION OF EPIDEMIOLOGY & COMMUNICABLE DISEASES I. Zika Virus preparedness and response Introduction: ZIKA, a mosquito borne virus was first identified in monkeys in
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 346/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 346/14 BEFORE: J.E. Smith: Vice-Chair HEARING: February 25, 2014 at Toronto Written DATE OF DECISION: March 13, 2014 NEUTRAL CITATION: 2014
More information